Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Entertainment Insider.
Too Lost Achieves No. 2 in Media & Entertainment and No. 7 NYC Placement on Inc. 5000 List
EIN Presswire
·
August 28, 2025
Too Lost music tech company in digital distribution and rights management, ranked #90 on the 2025 Inc. 5000 list of America’s fastest-growing private companies. NEW YORK, NY, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- Too Lost, a music...
Crusoe Expands Iceland Data Center Capacity with atNorth, Secures $175M Credit Facility from Victory Park Capital
GlobeNewswire, Inc.
·
August 25, 2025
SAN FRANCISCO, CHICAGO, and REYKJAVÍK, Iceland, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Crusoe, the industry’s first vertically integrated AI infrastructure provider, announced today with atNorth, a leading Nordic data center services provider, an...
OG of fast cars drops in games: Porsche adopts in-car gaming with AirConsole
GlobeNewswire, Inc.
·
August 28, 2025
Zurich, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AirConsole, the pioneering in-car gaming platform that transforms car rides into shared entertainment experiences, is arriving in the new Porsche Macan later this year. This collaboration will bring a...
Oculis to Participate in Upcoming September Investor Conferences
GlobeNewswire, Inc.
·
August 28, 2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant...
The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
GlobeNewswire, Inc.
·
August 28, 2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the...
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
GlobeNewswire, Inc.
·
August 25, 2025
Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian...
Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics
EIN Presswire
·
August 19, 2025
Icelandic venture capital firm Brunnur Ventures leads funding round to support development of breakthrough lipid nanoparticle delivery technologies BROOKLINE, MA, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Axelyf, Inc., a biotechnology...
Tourism Source Market to Grow at a CAGR of 6.6% and will Reach USD 1.1 Trillion by 2032
EIN Presswire
·
August 25, 2025
By tourist type, the group segment dominated the global market and is likely to remain dominant during the forecast period. WILMINGTON, DE, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- The Tourism Source Market Size was valued at $599.40...
MyBTCX.com Adds SEPA Bank Transfers for Instant Euro & Global Crypto Purchases
EIN Presswire
·
August 25, 2025
Eurozone and global users with SEPA-compatible banking can now fund crypto purchases quickly and securely on MyBTCX.com with low fees and non-custodial delivery SAN FRANCISCO, CA, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- MyBTCX.com,...
Oculis Reports Q2 2025 Financial Results and Provides Company Update
GlobeNewswire, Inc.
·
August 21, 2025
Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with topline results expected in Q2 2026 for the first potential eye drop to treat...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
GlobeNewswire, Inc.
·
August 21, 2025
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...
Multi-Day Elopements Rise for 2026 as Couples Turn Weddings into Immersive Adventures
EIN Presswire
·
August 8, 2025
Couples are trading one-day ceremonies for multi-day adventures, blending travel, culture, and love in unforgettable ways. REYKJAVIK, ICELAND, August 8, 2025 /EINPresswire.com/ -- Around the world, couples are re-imagining the way they say “I...
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
GlobeNewswire, Inc.
·
August 13, 2025
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq...
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
GlobeNewswire, Inc.
·
August 6, 2025
REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial...
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
GlobeNewswire, Inc.
·
August 12, 2025
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet...
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
GlobeNewswire, Inc.
·
August 19, 2025
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial demonstrating Rezdiffra reduced...
The Highlanderess Saga - A Gripping Historical Romance Series
EIN Presswire
·
August 8, 2025
When love, vengeance, and defiance shape the fate of nations by Top #1 International Novellist Eva Fellner LANDSBERG AM LECH, BAVARIA, GERMANY, August 8, 2025 /EINPresswire.com/ -- Historical novels are currently enjoying a renaissance—and with...
Whole Health at VA Pittsburgh
U.S. Department of Veterans Affairs
·
August 11, 2025
Enter through the front doors of the H. John Heinz III campus of the VA Pittsburgh Healthcare System on any given day and you might see Veterans doing yoga, tai chi, weightlifting and any number of other physical activities. What you’re really...
Century Aluminum Company Reports Second Quarter 2025 Results
GlobeNewswire, Inc.
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its second quarter 2025 results. Second Quarter 2025 Financial Results $MM (except shipments and per share data) Q2 2025 Q1 2025 Aluminum shipments...
Citing Benefits of 232 Tariffs, Century Aluminum Announces Restart to Bring Mt. Holly SC Plant to Full Production, Increasing U.S. Aluminum Production by 10%
GlobeNewswire, Inc.
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) has announced plans to restart over 50,000MT of idled production at its Mt. Holly, SC smelter. Century will invest approximately $50 million in the effort, create...